These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 14731311)

  • 21. Leukocytosis after lithium and clozapine combination therapy.
    Palominao A; Kukoyi O; Xiong GL
    Ann Clin Psychiatry; 2010 Aug; 22(3):205-6. PubMed ID: 20680194
    [No Abstract]   [Full Text] [Related]  

  • 22. [Drug treatment of schizophrenic psychoses in puerperium].
    Olbrich HM; Martin P
    Nervenarzt; 1994 Jul; 65(7):482-5. PubMed ID: 7800093
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clozapine for treatment-refractory mania.
    Calabrese JR; Kimmel SE; Woyshville MJ; Rapport DJ; Faust CJ; Thompson PA; Meltzer HY
    Am J Psychiatry; 1996 Jun; 153(6):759-64. PubMed ID: 8633686
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Obsessive-compulsive symptoms in adjunctive therapy with lamotrigine in clozapine-medicated patients.
    Szmulewicz AG; Valerio MP; Smith JM
    Schizophr Res; 2015 Aug; 166(1-3):364-5. PubMed ID: 26058675
    [No Abstract]   [Full Text] [Related]  

  • 25. Myoclonus in patients treated with clozapine: a case series.
    Bak TH; Bauer M; Schaub RT; Hellweg R; Reischies FM
    J Clin Psychiatry; 1995 Sep; 56(9):418-22. PubMed ID: 7665541
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Psychopharmacology. Clozapine and agranulocytosis.
    Feldman J
    Psychiatr Serv; 1996 Nov; 47(11):1177-8. PubMed ID: 8916231
    [No Abstract]   [Full Text] [Related]  

  • 27. Augmentation of clozapine with a second antipsychotic--a meta-analysis of randomized, placebo-controlled studies.
    Taylor DM; Smith L
    Acta Psychiatr Scand; 2009 Jun; 119(6):419-25. PubMed ID: 19245679
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Clozapine rechallenge after neutropenia in resistant schizophrenia: A review].
    Simon L; Cazard F
    Encephale; 2016 Aug; 42(4):346-53. PubMed ID: 27109327
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clozapine maintenance therapy in schizophrenia.
    Gaszner P; Makkos Z
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 May; 28(3):465-9. PubMed ID: 15093952
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clozapine: efficacy and safety.
    Buchanan RW
    Schizophr Bull; 1995; 21(4):579-91. PubMed ID: 8749886
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Augmentation of clozapine with ziprasidone in refractory schizophrenia: a double-blind, placebo-controlled study.
    Muscatello MR; Pandolfo G; Micò U; Lamberti Castronuovo E; Abenavoli E; Scimeca G; Spina E; Zoccali R; Bruno A
    J Clin Psychopharmacol; 2014 Feb; 34(1):129-33. PubMed ID: 24145221
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Violence and schizophrenia: clozapine as a specific antiaggressive agent.
    Buckley P; Bartell J; Donenwirth K; Lee S; Torigoe F; Schulz SC
    Bull Am Acad Psychiatry Law; 1995; 23(4):607-11. PubMed ID: 8639988
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Successful antimanic treatment and mood stabilization with lamotrigine, clozapine, and valproate in a bipolar patient after lithium-induced cerebellar deterioration. A case report.
    Dembowski C; Rechlin T
    Pharmacopsychiatry; 2003; 36(2):83-6. PubMed ID: 12734768
    [No Abstract]   [Full Text] [Related]  

  • 34. Can we prevent blood dyscrasia (leucopenia, thrombocytopenia) and epileptic seizures induced by clozapine.
    Herceg M; Muzinić L; Jukić V
    Psychiatr Danub; 2010 Mar; 22(1):85-9. PubMed ID: 20305597
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Addition of lamotrigine to clozapine in inpatients with chronic psychosis.
    Heck AH; de Groot IW; van Harten PN
    J Clin Psychiatry; 2005 Oct; 66(10):1333. PubMed ID: 16259551
    [No Abstract]   [Full Text] [Related]  

  • 36. Pimozide augmentation for the treatment of schizophrenic patients who are partial responders to clozapine.
    Friedman J; Ault K; Powchik P
    Biol Psychiatry; 1997 Sep; 42(6):522-3. PubMed ID: 9285089
    [No Abstract]   [Full Text] [Related]  

  • 37. Adjunct divalproex or lithium to clozapine in treatment-resistant schizophrenia.
    Kelly DL; Conley RR; Feldman S; Yu Y; McMahon RP; Richardson CM
    Psychiatr Q; 2006; 77(1):81-95. PubMed ID: 16397757
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The prevalence of akathisia in patients receiving stable doses of clozapine.
    Chengappa KN; Shelton MD; Baker RW; Schooler NR; Baird J; Delaney J
    J Clin Psychiatry; 1994 Apr; 55(4):142-5. PubMed ID: 7915271
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical management of clozapine patients in relation to efficacy and side-effects.
    Naber D; Holzbach R; Perro C; Hippius H
    Br J Psychiatry Suppl; 1992 May; (17):54-9. PubMed ID: 1358128
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of typical antipsychotic medications and clozapine on smooth pursuit performance in patients with schizophrenia.
    Friedman L; Jesberger JA; Meltzer HY
    Psychiatry Res; 1992 Jan; 41(1):25-36. PubMed ID: 1348583
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.